TERM ID="NYU_TERM_1" STRING="Current approaches" FREQUENCY=1 START=194 END=212 LEMMA="CURRENT APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Invasive mould disease" FREQUENCY=1 START=47 END=69 LEMMA="INVASIVE MOULD DISEASE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="growing threat" FREQUENCY=1 START=75 END=89 LEMMA="GROWING THREAT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="growing threat for immunocompromised patients" FREQUENCY=1 START=75 END=120 LEMMA="IMMUNOCOMPROMISED PATIENT GROWING THREAT" LEMMA_FREQUENCY=1 HEAD_TERM="growing threat" HEAD_LEMMA="GROWING THREAT"
TERM ID="NYU_TERM_5" STRING="immunocompromised patients" FREQUENCY=1 START=94 END=120 LEMMA="IMMUNOCOMPROMISED PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="invasive mould disease" FREQUENCY=1 START=24 END=46 LEMMA="INVASIVE MOULD DISEASE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_7" STRING="invasive mould disease Invasive mould disease" FREQUENCY=1 START=24 END=69 LEMMA="INVASIVE MOULD DISEASE INVASIVE MOULD DISEASE" LEMMA_FREQUENCY=1 HEAD_TERM="Invasive mould disease" HEAD_LEMMA="INVASIVE MOULD DISEASE"
TERM ID="NYU_TERM_8" STRING="mould-active antifungal agents" FREQUENCY=1 START=146 END=176 LEMMA="MOULD-ACTIVE ANTIFUNGAL AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="onco-haematology patients" FREQUENCY=1 START=340 END=365 LEMMA="ONCO-HAEMATOLOGY PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="optimum time" FREQUENCY=1 START=126 END=138 LEMMA="OPTIMUM TIME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="pre-emptive therapy" FREQUENCY=1 START=271 END=290 LEMMA="PRE-EMPTIVE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="prophylaxis" FREQUENCY=1 START=227 END=238 LEMMA="PROPHYLAXIS" LEMMA_FREQUENCY=1
